Metabolic Reprogramming of Gastric Cancer Revealed by a Liquid Chromatography–Mass Spectrometry-Based Metabolomics Study
Background/Objectives: Gastric cancer (GC) is a prevalent malignant tumor worldwide, with its pathological mechanisms largely unknown. Understanding the metabolic reprogramming associated with GC is crucial for the prevention and treatment of this disease. This study aims to identify significant alt...
Saved in:
| Main Authors: | Lina Zhou, Benzhe Su, Zexing Shan, Zhenbo Gao, Xingyu Guo, Weiwei Wang, Xiaolin Wang, Wenli Sun, Shuai Yuan, Shulan Sun, Jianjun Zhang, Guowang Xu, Xiaohui Lin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Metabolites |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-1989/15/4/222 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in the Study of Metabolic Reprogramming in Gastric Cancer
by: Yu Rong, et al.
Published: (2025-05-01) -
Somatic cell reprogramming for Parkinson's disease treatment
by: Xiaozhuo Li, et al.
Published: (2025-03-01) -
Chemical reprogramming ameliorates cellular hallmarks of aging and extends lifespan
by: Lucas Schoenfeldt, et al.
Published: (2025-06-01) -
Direct fibroblast reprogramming: an emerging strategy for treating organic fibrosis
by: Haohui Lin, et al.
Published: (2025-02-01) -
Integrative single-cell and spatial transcriptomics uncover ELK4-mediated mechanisms in NDUFAB1+ tumor cells driving gastric cancer progression, metabolic reprogramming, and immune evasion
by: Yuwei Sun, et al.
Published: (2025-07-01)